At InfoBionic.Ai, the year 2024 was guided by a simple question we have all been considering: ‘What if artificial intelligence could help clinicians see the invisible—the early signs of cardiac issues that are hiding in plain sight?’
Over the past 12 months, InfoBionic.Ai has brought that vision closer to reality. We have taken bold steps to push the boundaries of what’s possible through AI-enabled remote cardiac monitoring, empowering providers with actionable insights that ultimately improve outcomes and streamline patient care.
This year, our company rebranded from ‘InfoBionic’ to ‘InfoBionic.Ai’ to reflect our AI-driven vision. Through this transformation, we have earned industry recognition for innovation and impact and pioneered strategic partnerships that broke barriers and accelerated remote cardiac care. We also expanded our influence by becoming a pivotal voice for thought leadership, with over 17 articles published throughout the year by leading industry publications (all of which can be accessed in our News Center).
As we look back on 2024, we’re proud to highlight the moments that defined our commitment to advancing remote cardiac care—and the technologies and insights that are shaping the future of cardiology along the way. Read on to learn more about the top moments that defined the year for InfoBionic.Ai.
1. InfoBionic Becomes InfoBionic.Ai: A Milestone in Defining Better Cardiac Care
In early 2024, InfoBionic took a significant step forward by changing its name to InfoBionic.Ai, a name that reflects an unwavering commitment to advancing remote cardiac care through artificial intelligence. This evolution aligned with our mission to provide clinicians with the most precise, timely, and actionable insights that enhance patient outcomes and redefine the possibilities of remote cardiac monitoring.
The rebrand also highlighted the continued impact of our MoMe ARC®, an FDA-approved, AI-enabled 6-lead arrhythmia detection platform. This underscores our dedication to enabling earlier detection and more personalized care for patients by empowering clinicians with the tools they need to meet the demands of modern cardiac care.
Learn more about the significance of this transition and what it means for the future of cardiology in the full announcement here.
2. Spotlight on Cardiac Innovation: InfoBionic.Ai Appears on Health Uncensored with Dr. Drew
This April, InfoBionic.Ai and its MoMe ARC® had the privilege of being featured on the television series Health Uncensored with Dr. Drew Pinsky. The episode showcased the groundbreaking impact of the MoMe ARC®, our next-generation AI-enabled virtual cardiac telemetry solution, in collaboration with Cardiology Consultants of Philadelphia (CCP).
The discussion, which featured Dr. Colin Movsowitz of CCP, InfoBionic.Ai CEO Stuart Long, and InfoBionic.Ai COO Dave MacCutcheon, explored how advanced cardiac monitoring technology is reshaping patient care. From near real-time data availability to empowering “hospital-at-home” solutions, the MoMe ARC® demonstrates its potential to improve outcomes for patients and optimize workflows for clinicians. As cardiovascular disease continues to pose significant challenges, these appearances are a great opportunity to highlight how innovation is addressing the critical need for accessible, proactive cardiac diagnostics.
Missed the broadcast? Watch it here and learn more about the transformative advancements in cardiac care.
3. Revolutionizing Cardiology: InfoBionic.Ai and HBox.ai Join Forces
In May, we forged a partnership with HBox.ai to pioneer the first AI-driven comprehensive solution for the “Cardiology Clinic of the Future.” This collaboration combined InfoBionic.Ai’s advanced cardiac telemetry with HBox.ai’s virtual care model, creating an integrated platform for virtual consults, remote monitoring, chronic care, and diagnostic services.
This partnership exemplifies how innovation can empower cardiology practices to elevate patient care. By leveraging AI to enhance clinical insights and operational efficiency, the collaboration aims to reduce hospitalizations and improve outcomes, providing physicians with tools to better diagnose, predict, and manage cardiovascular risks. This initiative represents a shared vision of delivering the highest quality care through transformative technology.
Read the press release to see how this partnership is shaping the future of cardiology and empowering providers.
4. Advancing Early Detection: InfoBionic.Ai Partners with Anumana
This June, InfoBionic.Ai and Anumana joined forces to enhance the early detection of cardiac diseases through cutting-edge AI technology. By integrating Anumana’s ECG-AI™ algorithms with the MoMe ARC®, this collaboration pushes the boundaries of remote cardiac monitoring and diagnostics.
The partnership brings together two leaders in AI-driven healthcare innovation, combining Anumana’s expertise in ECG analysis—validated through its work with Mayo Clinic—with InfoBionic.Ai’s continuous, remote cardiac telemetry. They will work together to provide clinicians with powerful tools to identify conditions even earlier, enabling more timely interventions and quicker care.
Read the press release to learn how this partnership continues to revolutionize cardiac care and empower healthcare providers with actionable insights.
5. Shedding Light on Sleep and Heart Health: InfoBionic.Ai Featured on WTVM
In a televised interview with WTVM, InfoBionic.Ai CEO Stuart Long discussed the critical connection between sleep quality and heart health and how advancements in remote monitoring are transforming cardiac care. The segment highlighted how the MoMe ARC® equips clinicians with continuous, AI-enabled cardiac data to detect arrhythmias and other heart issues, even when symptoms are intermittent or occur during sleep.
With poor sleep recognized as a potential trigger for cardiac symptoms, this interview emphasized the importance of proactive monitoring to improve early detection and intervention. MoMe ARC®’s technology not only supports better diagnostic accuracy but also empowers providers to deliver more effective care, addressing heart health risks before they escalate—even when patients are sleeping.
Watch the full interview to learn how remote cardiac monitoring is improving patient outcomes in many aspects of life here.
6. Exploring AI’s Role in Cardiology: Insights from Two Podcasts
This year, InfoBionic.Ai’s CEO, Stuart Long, was asked to participate in two thought-provoking podcast discussions that highlighted how AI-powered remote cardiac monitoring is transforming the future of heart health. Both interviews offer valuable insights for healthcare professionals and anyone interested in the evolving role of AI in cardiology.
In an episode of the Medical AI Podcast, which tackled the question, “Is AI transforming cardiology?” Stuart discussed the critical role of AI in detecting irregular heart rhythms—often early indicators of heart attack and stroke. The episode explored how AI algorithms enhance detection accuracy, enabling earlier interventions and better patient outcomes. Listen to the full episode here.
On Trace3’s LiveAI Podcast, Stuart spoke about the future of heart health and how InfoBionic.Ai’s MoMe ARC® is pioneering advancements in remote cardiac care. The episode provided an in-depth look at the rigorous testing and implementation of AI in healthcare and highlighted the platform’s ability to deliver actionable insights to clinicians in near real-time. Watch the full conversation here.
7. Expanding Access: MoMe ARC® Added to Epic Showroom’s Connection Hub
In September, InfoBionic.Ai achieved a major milestone with the inclusion of the MoMe ARC® in the Connection Hub on Epic’s Showroom. This integration marked a significant advancement in making cutting-edge, AI-enabled remote cardiac monitoring technology more accessible to hospitals and clinics nationwide.
Epic’s Connection Hub is a trusted resource for healthcare professionals, showcasing solutions that enhance workflows and improve patient care. The MoMe ARC®’s integration with Epic’s EHR allows providers to streamline diagnostic processes, from ordering to results distribution, saving valuable time while maintaining exceptional care standards. This inclusion underscored InfoBionic.Ai’s commitment to empowering clinicians with tools that improve efficiency and enable more proactive cardiac care.
Read the press release to learn more about the MoMe ARC®’s inclusion in Epic’s Connection Hub.
8. Leading with Vision: Stuart Long Honored for Healthcare Innovation
In April 2024, InfoBionic.Ai CEO Stuart Long was honored by Worldcare Magazine as the ‘Most Pioneering Leader in the Healthcare Sector 2024.’ This award recognizes Stuart’s visionary leadership and dedication to advancing AI-powered healthcare solutions that improve patient outcomes and streamline clinical workflows.
With decades of experience at the intersection of healthcare and technology, Stuart has guided InfoBionic.Ai in developing groundbreaking solutions like the MoMe ARC®, empowering clinicians with timely, data-driven insights for remote cardiac monitoring. His focus on innovation, collaboration, and empathy continues to set new standards in patient care and healthcare technology.
Learn more about the award and Stuart’s leadership journey here.
9. Global Reach: InfoBionic.Ai Highlights Cardiac Innovation on U.K. Radio
This year, InfoBionic.Ai expanded its impact internationally as CEO Stuart Long took to the airwaves across the U.K. during Vascular Awareness Month 2024. Featured on over 180 stations—including BBC Three Counties, BBC Northamptonshire, SKY News Radio, and the On Air News Network—Stuart highlighted how AI-enabled remote patient monitoring is reshaping cardiac care.
With more than 20 hours of airtime and 52 million listeners, these interviews discussed the growing need for advanced tools that empower clinicians to detect and intervene in cardiac conditions earlier, improving outcomes for patients worldwide.
Learn more about the interviews and watch a clip here.
10. Setting the Standard: MoMe ARC® Earns Global Excellence Award
In June, the MoMe ARC® was honored with the ‘Best Mobile Cardiac Monitoring Platform 2024 – USA’ award in Global Health & Pharma’s Global Excellence Awards. This award celebrates innovation and excellence in healthcare, life sciences, and pharmaceutical technologies.
GHP’s Global Excellence Awards highlight companies and solutions that set new standards in care delivery, demonstrate cutting-edge innovation, and drive meaningful advancements in patient outcomes. Recipients are selected based on merit, discovery, and impact. This award recognizes the MoMe ARC® as a transformative tool in AI-enabled remote cardiac monitoring.
See InfoBionic.Ai’s award here.
Building on MoMentum: 2025 and Beyond
2024 proved to be a year of momentum for InfoBionic.Ai as we continued to advance remote cardiac care through innovative AI-enabled solutions. From enhancing early detection and diagnostics to enabling more proactive care, we’ve set the stage for even greater impact in the years ahead.
As we move into 2025, we’re excited to keep building on this momentum. With clinicians and patients at the center of our mission, we’ll continue to innovate, collaborate, and expand access to the technologies that make earlier detection and more personalized care possible. As we move forward, our focus remains clear—empowering healthcare providers with the tools and insights they need to deliver faster, smarter, and more effective cardiac care.
Thank you for being part of our journey. We’re excited to continue advancing cardiac care together in 2025. To learn more about how our solutions can transform cardiac care in your practice, contact us today.
